Bridgefront Capital, LLC
- SEC CIK
- 0001725690
- Latest filing
- Aug 14, 2026
ALLO holding history
Allogene Therapeutics, Inc. in every 13F filed by Bridgefront Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −10,781−100.0% | Sold out | Holders |
| Q2 2023 | 10,781 | $53.6K | <0.1% | −28,746−72.7% | Reduced | Holders |
| Q1 2023 | 39,527 | $195.3K | 0.1% | +39,527 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −20,512−100.0% | Sold out | Holders |
| Q3 2022 | 20,512 | $222.0K | 0.2% | +20,512 | New | Holders |